Phosphodiesterase as a New Therapeutic Target for the Treatment of Spinal Cord Injury and Neurodegenerative Diseases

Publisher： Bentham Science Publishers

E-ISSN： 1875-533x|21|24|2830-2838

ISSN： 0929-8673

Source： Current Medicinal Chemistry, Vol.21, Iss.24, 2014-08, pp. : 2830-2838

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

New perspectives for the treatment options in spinal cord injury

By Sharma Hari Shanker  

Expert Opinion on Pharmacotherapy, Vol. 9, Iss. 16, 2008-11 ,pp. : 2773-2800

Informa Healthcare

Access to resources Recommend Favorite

Editorial: New Avenues and Therapeutic Strategies for the Treatment of Neurodegenerative Diseases

By  

Current Pharmaceutical Design, Vol. 23, Iss. 5, 2017-03 ,pp. : 667-668

Bentham Science Publishers

Access to resources Recommend Favorite

NF-&kgr;B as a therapeutic target in neurodegenerative diseases

By Camandola Simonetta   Mattson Mark P  

Expert Opinion on Therapeutic Targets, Vol. 11, Iss. 2, 2007-02 ,pp. : 123-132

Informa Healthcare

Access to resources Recommend Favorite

Cyclin-Dependent Kinase 5 (Cdk5): A Potential Therapeutic Target for the Treatment of Neurodegenerative Diseases and Diabetes Mellitus

By  

Mini Reviews in Medicinal Chemistry, Vol. 7, Iss. 10, 2007-10 ,pp. : 1070-1074

Bentham Science Publishers

Access to resources Recommend Favorite

A Review on Response of Immune System in Spinal Cord Injury and Therapeutic Agents useful in Treatment

By  

Current Pharmaceutical Biotechnology, Vol. 16, Iss. 1, 2015-01 ,pp. : 26-34

Bentham Science Publishers

Access to resources Recommend Favorite